Search results for " article"

showing 10 items of 6903 documents

Calculation of NNTs in RCTs with time-to-event outcomes: A literature review

2008

Abstract Background The number needed to treat (NNT) is a well-known effect measure for reporting the results of clinical trials. In the case of time-to-event outcomes, the calculation of NNTs is more difficult than in the case of binary data. The frequency of using NNTs to report results of randomised controlled trials (RCT) investigating time-to-event outcomes and the adequacy of the applied calculation methods are unknown. Methods We searched in PubMed for RCTs with parallel group design and individual randomisation, published in four frequently cited journals between 2003 and 2005. We evaluated the type of outcome, the frequency of reporting NNTs with corresponding confidence intervals,…

medicine.medical_specialtyEpidemiologyMEDLINEHealth Informaticslaw.inventionRandomized controlled triallawStatisticsConfidence IntervalsHumansMedicineRandomized Controlled Trials as Topiclcsh:R5-920business.industryAbsolute risk reductionConsolidated Standards of Reporting TrialsConfidence intervalClinical trialSample size determinationData Interpretation StatisticalSample SizeNumber needed to treatPhysical therapylcsh:Medicine (General)businessResearch ArticleBMC Medical Research Methodology
researchProduct

SARS-CoV-2 outbreak in medical employees in a large urologic department: Spread, containment and outcome.

2021

Background The SARS-CoV-2 pandemic presents an unprecedented challenge to health care systems worldwide. Data on SARS-CoV-2 transmission in a hospital is rare and outbreaks among health care professionals are complex to control. Material and Methods Over the course of 6 consecutive weeks we recorded data on an exponential outbreak of SARS-CoV-2 within our department. We reconstructed the assumed route of the spread of infection, and the employees’ acute and late symptoms. Increasing preventive measures (mandatory face masks, intense training in hygiene, physical distancing whenever possible, and termination of visits from outside the hospital) were implemented. Results Within 6 weeks, 13 em…

medicine.medical_specialtyEpidemiologymedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health PersonnelDisease Outbreaks03 medical and health sciences0302 clinical medicineHygienePandemicHealth careMajor ArticleMedicineHumans030212 general & internal medicinePandemicsmedia_common0303 health sciencesViral spreadPandemic030306 microbiologybusiness.industryTransmission (medicine)Medical settingSARS-CoV-2Health PolicyPublic Health Environmental and Occupational HealthOutbreakCOVID-19Face masksInfectious DiseasesEmergency medicinebusinessAmerican journal of infection control
researchProduct

Differences in cardiac structure and function between black and white patients: Another step in the evaluation of cardiovascular risk in chronic kidn…

2017

medicine.medical_specialtyEuropean Continental Ancestry Group030232 urology & nephrologyMEDLINE030204 cardiovascular system & hematologyLeft ventricular hypertrophyWhite PeopleCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCardiovascular DiseaseInternal MedicinemedicineHumansCardiac structureRenal Insufficiency ChronicFramingham Risk ScoreWhite (horse)business.industryRisk Factormedicine.diseaseCardiovascular DiseasesCardiologyOriginal ArticleCohort StudiebusinessCohort studyKidney diseaseHuman
researchProduct

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

2018

Background: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients with chronic primary immune thrombocytopenia (ITP). Methods: In this phase III multinational, multicentre, prospective, uncontrolled, open-label, single-arm study, adult patients with a baseline platelet count < 30 × 10 9 /L were treated with IVIG 10% at a dose of 2 g/kg body weight administered over 2 consecutive days. The primary endpoint was Response over the study period and was defined accor…

medicine.medical_specialtyEuropean Medicines Agency guidelinesPlatelet countRenal functionHigh dose030204 cardiovascular system & hematologyGastroenterology03 medical and health sciencesIntravenous immunoglobulin; High dose; Immune thrombocytopenia; Response; European Medicines Agency guidelines; Platelet count; Bleeding assessment; Infusion rate0302 clinical medicineInfusion rateInternal medicinemedicineClinical endpointPlateletAdverse effectIntravenous immunoglobulinbiologybusiness.industryResponseGuidelineImmune thrombocytopeniaImmune thrombocytopenia030220 oncology & carcinogenesisConcomitantbiology.proteinBleeding assessmentOriginal ArticleAntibodybusinessJournal of Hematology
researchProduct

Effects of training on attitudes of psychiatric personnel towards patients who self-injure

2016

Background Improving attitudes of personnel towards self-injurious patients leads to better working alliance and contributes to better patient outcomes. Previous research into the improvement of these attitudes has recorded the need for specific training in evidence-based assessment and treatment of self-injurious patients. Aim The current study describes the attitudes towards self-injurious patients among psychiatric personnel. The study also evaluates the effect of a structured clinical training program on psychiatric personnel's attitudes towards patients who self-injure. It further examines whether age, education, frequency of self-injurious patients contact, and work experience of the …

medicine.medical_specialtyEvidence-based practiceevidence‐based practiceevidence-based practiceself-injuryPoison controlasenteetNursingSuicide preventionOccupational safety and health03 medical and health sciences0302 clinical medicineInjury preventionMedicineharjoittelu030212 general & internal medicinePsychiatryta515General NursingResearch ArticlestrainingSuicide attemptbusiness.industryHuman factors and ergonomicsself‐injuryUSPWork experience030227 psychiatrypsychiatricAttitudespersonnelbusinessClinical psychologyResearch Article
researchProduct

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.

2019

Abstract The objective of this scoping review is to summarize the current use of pharmacokinetics for tailoring prophylaxis in hemophilia patients switching between clotting factor products. Patients with hemophilia may require switching of clotting factor concentrates due to a variety of factors, but there have been perceived risks associated with switching, such as inhibitor development or suboptimal protection due to inadequate dosing while titrating treatment. Studies that look at patients switching from one clotting factor concentrate to another are categorized in terms of their primary and/or secondary objectives, notably biosimilarity and comparative pharmacokinetic studies and inhib…

medicine.medical_specialtyFactor concentrate610 Medicine & healthReview Article030204 cardiovascular system & hematologyHemophilia ADrug SubstitutionHemophilia BFactor IX03 medical and health sciencesDrug substitution0302 clinical medicinePharmacokineticsmedicineDosingIntensive care medicineFactor IXClotting factorOriginal Articles: Haemostasisfactor IXFactor VIIIlcsh:RC633-647.5business.industryDosing regimenlcsh:Diseases of the blood and blood-forming organsHematology3. Good healthOnline‐only Articlesfactor VIII3121 General medicine internal medicine and other clinical medicinedrug substitution10032 Clinic for Oncology and Hematologydrug substitution; factor IX; factor VIII; hemophilia A; hemophilia Bhemophilia Bhemophilia Abusiness030215 immunologymedicine.drug
researchProduct

Sphincter damage during fistulotomy for perianal fistulae and its relationship with faecal incontinence.

2021

Abstract Background The length of sphincter which can be divided during fistulotomy for perianal fistula is unclear. The aim was to quantify sphincter damage during fistulotomy and determine the relationship between such damage with symptoms and severity of faecal incontinence and long-term quality of life (QOL). Methods A prospective cohort study was performed over a 2-year period. Patients with intersphincteric and mid to low transsphincteric perianal fistulas without risk factors for faecal incontinence were scheduled for fistulotomy. All patients underwent 3D endoanal ultrasound (3D-EAUS) pre-operatively and 8 weeks postoperatively. Measurements were taken of pre- and postoperative anal…

medicine.medical_specialtyFistulaExternal anal sphincterAnusFistulaAnal CanalFistulotomyFistulotomyInternal anal sphincterAnal ultrasoundEndoanal ultrasoundPerianal fistulaeMedicineHumansRectal FistulaProspective StudiesProspective cohort studyIncontinenceCirurgiabusiness.industrydigestive oral and skin physiologyFaecal incontinencemedicine.diseaseSurgerymedicine.anatomical_structureMalaltiesQuality of LifeSphincterSurgeryOriginal ArticlebusinessFecal IncontinenceAbdominal surgeryLangenbeck's archives of surgery
researchProduct

A prospective analysis of the injury incidence of young male professional football players on artificial turf

2016

Background: The effects of synthetic surfaces on the risk of injuries is still debated in literature and the majority of published data seems to be contradictory. For such reasons the understanding of injury incidence on such surfaces, especially in youth sport, is fundamental for injury prevention. Objectives: The aim of this study was to prospectively report the epidemiology of injuries in young football players, playing on artificial turfs, during a one sports season. Patients and Methods: 80 young male football players (age 16.1 ± 3.7 years; height 174 ± 6.6 cm; weight 64.2 ± 6.3 kg) were enrolled in a prospective cohort study. The participants were then divided in two groups; the first…

medicine.medical_specialtyFootball; Incidence; Injuries; Soccer; Young; Orthopedics and Sports MedicineFootballYoungPoison controlFootball03 medical and health sciences0302 clinical medicineEpidemiologyInjury preventionArtificial turfSoccermedicineOrthopedics and Sports MedicineProspective cohort study030222 orthopedicsInjuriesGroinbusiness.industryIncidence (epidemiology)Incidence030229 sport sciencesInjuriemedicine.anatomical_structurePhysical therapybusinesshuman activitiesResearch Article
researchProduct

Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2

2012

Tumor vessel dysfunction is a pivotal event in cancer progression. Using an in vivo neovascularization model, we identified G protein–coupled receptor kinase 2 (GRK2) as a key angiogenesis regulator. An impaired angiogenic response involving immature vessels was observed in mice hemizygous for Grk2 or in animals with endothelium-specific Grk2 silencing. ECs isolated from these animals displayed intrinsic alterations in migration, TGF-β signaling, and formation of tubular networks. Remarkably, an altered pattern of vessel growth and maturation was detected in postnatal retinas from endothelium-specific Grk2 knockout animals. Mouse embryos with systemic or endothelium-selective Grk2 ablation …

medicine.medical_specialtyG-Protein-Coupled Receptor Kinase 2Angiogenic SwitchAngiogenesisMedicinaActivin Receptors Type IIMelanoma ExperimentalReceptor Transforming Growth Factor-beta Type INeovascularization PhysiologicProtein Serine-Threonine KinasesBiologyMural cellGrk2Transforming Growth Factor beta1NeovascularizationMiceDownregulation and upregulationCell MovementPregnancyInternal medicinemedicineAnimalsHumansCell ProliferationHemizygoteMice KnockoutG protein-coupled receptor kinaseTumorNeovascularization PathologicEndothelial CellsRetinal VesselsG proteinGeneral MedicineCell biologyEndocrinologymedicine.anatomical_structurecardiovascular systemFemalePericyteSignal transductionmedicine.symptomActivin Receptors Type IReceptors Transforming Growth Factor betaSignal TransductionResearch Article
researchProduct

Bovine gangliosides and acute motor polyneuropathy.

1992

medicine.medical_specialtyGangliosidebusiness.industryGeneral EngineeringMEDLINEPolyradiculoneuropathyGeneral Medicinemedicine.diseaseSurgeryInternal medicineGeneral Earth and Planetary SciencesMedicinebusinessMotor polyneuropathyPolyneuropathyGeneral Environmental ScienceResearch Article
researchProduct